04:29 PM EDT, 08/08/2024 (MT Newswires) -- Gilead Sciences ( GILD ) reported Q2 non-GAAP earnings late Thursday of $2.01 per diluted share, compared with $1.34 a year earlier.

Analysts polled by Capital IQ expected $1.60.

Revenue for the quarter ended June 30 was $6.95 billion, compared with $6.60 billion a year earlier.

Analysts polled by Capital IQ expected $6.74 billion.

For full-year 2024, the company is projecting non-GAAP EPS of $3.60 to $3.90, up from its prior outlook expecting $3.45 to $3.85. Analysts polled by Capital IQ are looking for $3.71.

The company said its board maintained the quarterly dividend at $0.77 per share, payable on Sept. 27 to stockholders of record on Sept. 13.

Price: 75.38, Change: -0.21, Percent Change: -0.28